Improving Natural Killer Cells’ Ability To Fight Malaria

Malaria is caused by mosquito-borne parasites of the genus Plasmodium, which affects over 216 million people worldwide. It is still a huge problem in developing countries because there is no good vaccine for malaria, and antimalarial drugs are losing their efficacy with drug resistance on the rise, especially in Africa and South-east Asia. In 2017 alone, there were 445,000 malaria deaths globally.

The body’s first line of defense against malaria is the innate immune system, and one of the earliest cells to respond and kill the parasites are the natural killer (NK) cells. The outcome of this early response can determine whether severe malaria will occur. Interestingly, the response of NK cells towards malaria parasite is not the same in everyone — NK cells from some individuals kill more parasites (responsive), while those from others kill less (non-responsive) — and no one knows why this happens. When we compare the NK cells from malaria patients with severe disease against those with mild disease, we observe that NK cells from patients with severe disease were less responsive than NK cells from patients with mild disease. This spurred us to ask why NK cells from different individuals respond to malaria differently.

This is an image of a NK cell membrane (labeled in green) fusing with a red colored malaria-microvesicle. Image credit: Weijian Ye.

By comparing responsive and non-responsive NK cells, we found that when exposed to malaria parasites, responsive NK cells have a higher expression of a molecule, MDA5, compared to non-responsive NK cells. MDA5 is a receptor that detects foreign nucleic acid, and in response to it, MDA5 activates NK cells. MDA5 is classically associated with viral infections — when a virus infects a cell, it brings along its viral nucleic acids into the cell, thus exposing them to MDA5 recognition. However, in the case of malaria, which doesn’t infect NK cells, things are not so direct.

So, how does MDA5 detect malaria nucleic acids when malaria doesn’t infect NK cells? We found that NK cells fuse with malaria-derived membranous microvesicles, which have diameters under one micrometer. These microvesicles contain malaria nucleic acids and are secreted by malaria-infected cells, serving as a form of cell-to-cell communication. Via the exchange of nucleic acids, drug resistance genes can be passed between malaria-infected cells. On this note, the fusing of NK cells with microvesicles releases malaria nucleic acids into the NK cell, thereby triggering MDA5. MDA5 then activates NK cells, and cause them to go into a “high-alert” state. This increases the ability of NK cells in surveying its surrounding, leading to the improved killing of malaria-infected cells.

Having found the signals required to trigger MDA5, we then packaged synthetic nucleic acids into membranous microvesicles and asked if these synthetic microvesicles can help to improve the response of non-responsive NK cells. Indeed, when we expose non-responsive NK cells to these synthetic microvesicles in addition to malaria-infected cells, we observe that the non-responsive NK cells now kill better, reaching almost the same malaria-killing efficiency as responsive NK cells. This represents a new paradigm for the treatment of infectious diseases such as malaria. In contrast to traditional anti-malaria drugs which target the parasite itself, our new treatment targets cells of the body’s immune system. This prevents the generation of drug resistance, as there is no drug-pressure directed at the parasite. In addition, as the treatment increases the responsiveness of the body’s immune system against foreign pathogens, it is also possible to utilize similar immune-modulating drugs against other infectious diseases.

From left to right: Authors Marvin Chew, Weijian Ye and Corresponding author Prof. Peter Preiser. Image courtesy Weijian Ye.
These findings are described in the article entitled Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway, recently published in the journal PLOS Pathogens.

About The Author

Weijian Ye

Weijian is a researach scientist at Nanyang Technological University and recipient of the prestigious Lee Kuan Yew Gold medal, with over 6 years of experience in molecular biology and NK cell immunology. Weijian has 2 years of industrial R&D, developing enzymes for green revolution of industrial processes, as well as over 5 years of experience in immunology and infectious disease. He has discovered drugs for immunotherapy of infectious disease and published 5 internationally peer-reviewed papers on Natural Killer Cells, Malaria, Dengue and microfluidics

Speak Your Mind!

READ THIS NEXT

Meta-Analysis Of Functionality In Current And Abstinent Cannabis Users

Cannabis is the most commonly used illicit drug worldwide, and legislative changes have been made in some parts to remove its controlled substance status. This is despite evidence to suggest cannabis’ association with adverse effects, such as decreased memory functioning, failure to hold attention and, most worryingly, the development of psychotic disorders. What alterations underlie […]

Homeowners Respond To Energy Efficiency Thresholds When Investing In Home Retrofits

Ireland has a system to grade the energy efficiency of residential buildings, called a Building Energy Rating (BER). A BER is a standardized assessment of a property’s energy requirements for space and water heating, ventilation, and lighting, fewer savings from energy generation technologies. It is calculated in terms of kWh/m2/year of energy consumption from which […]

Electrochemical Additive Manufacturing: A Low Cost Desktop 3D Printer

Additive manufacturing, or 3D printing as it is commonly known, enables the creation of complex 3D geometries through the selective layer-by-layer deposition of material. The versatility of 3D printing as a manufacturing process removes the need for specific tooling allowing the process to have significantly reduced production times compared to traditional subtractive manufacturing processes such […]

Disrupting The Brain Keeper To Allow Silencing Of Deleterious Genes In The Nervous System

Therapeutic oligonucleotides, such as small interfering RNAs (siRNA), hold great promise for the treatment of genetically-defined disorders, including diseases of the central nervous system (CNS). These oligonucleotide-based drugs effectively and potently modulate gene expression of toxic RNAs and proteins, potentially blocking or reversing disease progression. Despite the significant enthusiasm of the scientific community after their […]

Improving The Characteristics Of Renewable Fuel Combustion

The heat coming out from the oxidation of hydrocarbons which is identified by combustion is a major source of energy responsible for almost 98% of total energy worldwide. The prevalent types of the fuels used in the combustion for the production of energy were hydrocarbons which are being extracted from the shell of the earth. […]

The Plan Of Four-Dimensional Regulation (4D Plan) For Cancer Patients: First Systematic Plan For Cancer Patients In The World

Cancer is still a global issue. Surgery, chemotherapy, radiotherapy, and present immune therapy do prolong the lives of cancer patients, but these cannot correct a disordered immune system, a result of cancer. Free radicals are often hazardous to patients and can damage all major components of cells, including DNA, proteins, and cell membranes. The damage […]

Defrosted 42,000 Year Old Nematodes Found Alive!

The oldest organisms alive were born while humans were busy learning how to fish and make instruments, nearly 42 000 years ago. What was the Earth like in those days? For thousands of years, these ancient organisms have been frozen in the soil in Siberia, but with the help of Russian scientists, they have been […]